Coloplast A/S CBHD.F

Healthcare · Medical Instruments & Supplies · valued as of 2026-11-02 · statements 2024-09-30

Average Intrinsic Value
$8.86B
Market Cap
$14.08B
Margin of Safety
-58.8%
Intrinsic / Market Ratio
0.63

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

10.29B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

8.23B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

8.07B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

8.86B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

8.86B USD

from the sum above

Market Cap

14.08B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.63×

the ratio the screener ranks by; Margin of Safety -58.8% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 10.29B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)13.80B USD
−②Net Debt Today3.52B USD
+③Growth Value0 USD
=Value10.29B USD

EPV of the Operations (NOPAT over WACC)

13.80B USD

Net debt today

-3.52B USD

Growth Value

0 USD

Value

10.29B USD

①EPV (earnings power value)

13.80B USD

②Net Debt Today

3.52B USD

③Growth Value

0 USD

Market value

Market Cap14.08B USD

Today's price times the shares.

Value vs market

Margin of Safety-36.8%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 8.23B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE6.74B USD
+②Equity at Year 15, Today1.50B USD
=Value8.23B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

6.74B USD

②Equity at Year 15, Today

1.50B USD

Market value

Market Cap14.08B USD

Today's price times the shares.

Value vs market

Margin of Safety-71.0%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 8.07B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF7.85B USD
+②Invested Capital at Year 15, Today3.73B USD
−③Net Debt Today3.52B USD
=Value8.07B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

7.85B USD

②Invested Capital at Year 15, Today

3.73B USD

③Net Debt Today

3.52B USD

Market value

Market Cap14.08B USD

Today's price times the shares.

Value vs market

Margin of Safety-74.5%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 6.78%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.56×Market Risk Premium 6.00%= 7.87%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 201.39M USDPretax Income 958.95M USD= 21.00%

The tax the interest saves.

Interest Expense =EBIT 1.08B USD−Pretax Income 958.95M USD= 119.21M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 119.21M USDTotal Debt 3.64B USD×(1 − Tax Rate for WACC 21.00%)= 2.59%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 3.64B USDMarket Cap + Total Debt 14.08B USD + 3.64B USD= 20.54%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 79.46%×Cost of Equity 7.87%+Debt Weight 20.54%×Cost of Debt 2.59%= 6.78%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 7.18B USD − Total Liabilities 5.13B USD = Book Value Today 2.04B USD

Total Debt 3.64B USD − Cash and Short-Term Investments 124.95M USD = Net Debt Today 3.52B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 16.2%at most 5%does not pass225,368,138 / 212,307,124
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets-4.8%at least -10.0%passes(414.77M USD − 757.57M USD) ÷ 7.18B USD
Price to bookMarket Cap ÷ Book Value Today6.89×at most 3×does not pass14.08B USD ÷ 2.04B USD
Operating marginOperating Income ÷ Revenue27.0%above 10.0%passes1.09B USD ÷ 4.05B USD
Revenue growthRevenue ÷ Revenue a Year Before − 116.7%above 10.0%passes4.05B USD / 3.47B USD
Net cash(Cash − Total Debt) ÷ Market Cap-25.0%above -30%passes(124.95M USD − 3.64B USD) ÷ 14.08B USD
Operating efficiencyOperating Income ÷ Gross Profit39.9%above 25.0%passes1.09B USD ÷ 2.74B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

56 USD

Enterprise value

35.58B USD

market cap plus net debt

EV / EBITDA

4.12×

Price / book

7.02×

the provider's book

Price / earnings

33.96×

Return on equity

18.5%

the provider's, not the engine's

Profit margin

9.7%

Revenue growth

5.7%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2021202220232024
Income statement

Revenue

3.03B2.99B3.47B4.05B

Gross profit

2.08B2.05B2.32B2.74B

Operating income

992.52M914.28M970.56M1.09B

EBITDA

operating income before depreciation and amortisation

1.10B956.49M1.10B1.27B

Pretax income

973.47M810.68M854.29M958.95M

Net income

753.57M622.66M678.19M757.57M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

774.36M687.80M677.85M742.52M

R&D

117.92M114.58M123.64M136.91M
Balance sheet, year end

Total assets

2.47B4.95B6.83B7.21B

Total liabilities

1.20B3.86B4.38B4.52B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

1.28B1.10B2.45B2.69B

Total debt

435.12M2.48B2.77B3.39B

Cash and equivalents

69.97M54.78M129.17M118.16M

Net PP&E

fixed assets after depreciation

685.00M681.54M847.77M985.34M

Working capital

current assets less current liabilities

106.20M190.00M-903.77M35.99M
Cash flow

Operating cash flow

826.19M674.66M599.21M414.77M

Capital expenditure

paid out, so below zero

-307.05M-150.17M-175.96M-201.84M

Depreciation and amortisation

123.69M123.05M151.57M193.44M

Free cash flow

operating cash flow plus capital expenditure

519.14M524.49M423.25M212.93M